Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Leukemia|November 1, 1994
A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trialW R Vogler, D L McCarley, M Stagg, et al.
Cancer Research|April 1, 1976
The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusionZ H Israili, W R Vogler, E S Mingioli, et al.
Blood|September 15, 1992
Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipidW R Vogler, W E Berdel, A C Olson, et al.
Cancer Research|March 1, 1987
Differential effects of various protein kinase C activators on protein phosphorylation in human acute myeloblastic leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1aZ Kiss, E Deli, M Shoji, et al.
Cancer Research|May 15, 1990
Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analoguesB Zheng, K Oishi, M Shoji, et al.
Cancer Research|February 15, 1988
Influence of 1-beta-D-arabinofuranosylcytosine conjugates of lipids on the growth and metastasis of Lewis lung carcinomaW E Berdel, S Danhauser, C I Hong, et al.
Progress in Clinical and Biological Research|January 1, 1982
Influence of quantity of granulocytes transfused on responseE F Winton, S Moffitt, W R Vogler, et al.
The Journal of Biological Chemistry|April 22, 1994
Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoproteinB Zheng, T C Chambers, R L Raynor, et al.
Leukemia Research|March 1, 1994
Effect of herbimycin A, an inhibitor of tyrosine kinase, on protein tyrosine kinase activity and phosphotyrosyl proteins of Ph1-positive leukemia cellsM Okabe, K Kawamura, T Miyagishima, et al.
Leukemia|October 1, 1992
Phase II clinical trial of carboplatin in relapsed and refractory leukemiaW R Vogler, D P Harrington, E F Winton, et al.
Pageof 12